A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells.
A peptide-guided prodrug incorporating a tumor-specific peptide, doxorubicin, and a pH-sensitive hydrazone bridge was developed for targeted ablation of cancer cells with minimal side cytotoxicity.